Engineered T cells that have been used to treat ulcerative colitis, rheumatoid arthritis and lupus show promising results.

Once-weekly tirzepatide is associated with clinically relevant reductions in SUA levels over 72 weeks, largely driven by substantial weight loss.

Decreasing precipitation and rising populations could bring a perfect storm of water shortages for the United States. Where is our water going? A thunderstorm sweeps across Nevada, a state in which ...